Adiponectin-Resistance in Obesity

Area of Science:

• Endocrinology
• Metabolic Syndrome Research
• Obesity Pathophysiology

Background:

• Decreased adiponectin levels correlate with inflammation in obesity.
• Hypertrophic adipocytes drive insulin resistance and metabolic syndrome.
• Macrophage polarization influences adiponectin receptor (AdipoR1/R2) expression and inflammatory responses.

Purpose of the Study:

• To investigate the mechanisms underlying adiponectin resistance in obesity.
• To explore the role of adiponectin receptors (AdipoR1/R2) and adaptor protein (APPL1/APPL2) in adiponectin signaling.
• To understand the link between adiponectin resistance, insulin resistance, and cardiovascular disease risk.

Main Methods:

• Analysis of adiponectin and adiponectin receptor (AdipoR1/R2) expression in obese subjects.
• Investigation of the role of adaptor proteins APPL1 and APPL2 in adiponectin signaling pathways.
• Correlation studies between adiponectin resistance, insulin resistance, and inflammation markers.

Main Results:

• Reduced adiponectin levels and AdipoR1/R2 mRNA expression are observed in obesity.
• APPL1/APPL2 expression levels alter adiponectin activity, with APPL2 inhibiting signaling.
• Adiponectin resistance is linked to insulin resistance, forming a detrimental cycle.
• Diet-induced hyperlipidemia is a primary cause of vascular adiponectin resistance.

Conclusions:

• Adiponectin resistance, exacerbated by impaired receptor signaling and APPL1/APPL2 interactions, contributes significantly to obesity-related metabolic dysfunction.
• The interplay between adiponectin resistance and insulin resistance creates a vicious cycle, increasing the risk of cardiovascular diseases.
• Understanding these pathways is crucial for developing therapeutic strategies against obesity and its complications.